DE69414115T2 - Vitamin d analoge - Google Patents

Vitamin d analoge

Info

Publication number
DE69414115T2
DE69414115T2 DE69414115T DE69414115T DE69414115T2 DE 69414115 T2 DE69414115 T2 DE 69414115T2 DE 69414115 T DE69414115 T DE 69414115T DE 69414115 T DE69414115 T DE 69414115T DE 69414115 T2 DE69414115 T2 DE 69414115T2
Authority
DE
Germany
Prior art keywords
alpha
vitamin
azide
optionally substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69414115T
Other languages
English (en)
Other versions
DE69414115D1 (de
Inventor
Robert Hesse
Malathi Ramgopal
Gaddam Reddy
Sundara Setty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RES INST MEDICINE CHEM
Original Assignee
RES INST MEDICINE CHEM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RES INST MEDICINE CHEM filed Critical RES INST MEDICINE CHEM
Publication of DE69414115D1 publication Critical patent/DE69414115D1/de
Application granted granted Critical
Publication of DE69414115T2 publication Critical patent/DE69414115T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DE69414115T 1993-07-23 1994-07-22 Vitamin d analoge Expired - Fee Related DE69414115T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939315253A GB9315253D0 (en) 1993-07-23 1993-07-23 Chemical compounds
PCT/GB1994/001587 WO1995003273A1 (en) 1993-07-23 1994-07-22 Vitamin d analogues

Publications (2)

Publication Number Publication Date
DE69414115D1 DE69414115D1 (de) 1998-11-26
DE69414115T2 true DE69414115T2 (de) 1999-04-08

Family

ID=10739292

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69414115T Expired - Fee Related DE69414115T2 (de) 1993-07-23 1994-07-22 Vitamin d analoge

Country Status (20)

Country Link
US (2) US5872140A (de)
EP (1) EP0710227B1 (de)
JP (1) JPH09500637A (de)
KR (1) KR100321415B1 (de)
CN (1) CN1043883C (de)
AT (1) ATE172451T1 (de)
AU (1) AU690565B2 (de)
CA (1) CA2167837A1 (de)
CZ (1) CZ20796A3 (de)
DE (1) DE69414115T2 (de)
DK (1) DK0710227T3 (de)
ES (1) ES2125466T3 (de)
FI (1) FI113535B (de)
GB (1) GB9315253D0 (de)
HU (1) HU221597B (de)
IL (1) IL110415A (de)
NO (1) NO314453B1 (de)
NZ (1) NZ268659A (de)
WO (1) WO1995003273A1 (de)
ZA (1) ZA945427B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DE19935771A1 (de) 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
DK1220676T3 (da) 1999-09-29 2005-09-05 Colotech As Forebyggelse af colorektal cancer
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6555573B2 (en) * 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US20030105031A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Methods for the treatment of skin disorders
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
AU2003283101B2 (en) * 2002-11-04 2008-12-11 Dsm Nutritional Products Ag Microcapsules having multiple shells and method for the preparation thereof
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US8034450B2 (en) * 2005-01-21 2011-10-11 Ocean Nutrition Canada Limited Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof
US20080139649A1 (en) * 2005-01-27 2008-06-12 Barrow Colin J Fatty Acid-Benzenediol Derivatives and Methods of Making and Using Thereof
CA2556520C (en) * 2005-01-27 2008-10-28 Ocean Nutrition Canada Ltd. Chromium-fatty acid compounds and methods of making and using thereof
US9968120B2 (en) * 2006-05-17 2018-05-15 Dsm Nutritional Products Ag Homogenized formulations containing microcapsules and methods of making and using thereof
EP2007224A2 (de) * 2006-04-07 2008-12-31 Ocean Nutrition Canada Limited Emulsionen und mikrokapseln mit stoffen mit geringer grenzflächenspannung, herstellungsverfahren und verwendung
WO2008017962A2 (en) * 2006-06-05 2008-02-14 Ocean Nutrition Canada Ltd. Microcapsules with improved shells
JP2010515455A (ja) 2007-01-10 2010-05-13 オーシャン ニュートリッション カナダ リミテッド 菜食マイクロカプセル
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
SG173119A1 (en) * 2009-01-27 2011-08-29 Berg Biosystems Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
CN105663146B (zh) 2009-08-14 2020-09-11 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
WO2012158794A1 (en) 2011-05-17 2012-11-22 Wisconsin Alumni Research Foundation N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
WO2014194133A1 (en) 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
CN104926739B (zh) * 2015-06-09 2017-06-27 南京理工大学 基于氮杂环修饰的维生素d2衍生物、合成及应用
US10548908B2 (en) 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0078704B1 (de) * 1981-11-02 1987-04-29 Research Institute For Medicine And Chemistry Inc. Zwischenprodukte in der Synthese von Vitamin D Derivaten
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
IL107185A (en) * 1992-10-06 1998-02-22 Schering Ag History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them
US5446635A (en) * 1993-06-24 1995-08-29 Quarton, Inc. Laser assembly for marking a line on a workpiece for guiding a cutting tool

Also Published As

Publication number Publication date
IL110415A0 (en) 1996-03-31
NZ268659A (en) 1996-09-25
CN1043883C (zh) 1999-06-30
EP0710227A1 (de) 1996-05-08
GB9315253D0 (en) 1993-09-08
AU690565B2 (en) 1998-04-30
US6013814A (en) 2000-01-11
KR100321415B1 (ko) 2002-11-13
CA2167837A1 (en) 1995-02-02
NO314453B1 (no) 2003-03-24
DE69414115D1 (de) 1998-11-26
DK0710227T3 (da) 1999-06-28
CN1129441A (zh) 1996-08-21
ATE172451T1 (de) 1998-11-15
EP0710227B1 (de) 1998-10-21
NO960251L (no) 1996-03-22
ES2125466T3 (es) 1999-03-01
FI113535B (fi) 2004-05-14
HUT73846A (en) 1996-09-30
JPH09500637A (ja) 1997-01-21
IL110415A (en) 2000-01-31
AU7193994A (en) 1995-02-20
ZA945427B (en) 1995-08-24
WO1995003273A1 (en) 1995-02-02
HU9600136D0 (en) 1996-03-28
FI960303A (fi) 1996-03-22
HU221597B (hu) 2002-11-28
NO960251D0 (no) 1996-01-22
FI960303A0 (fi) 1996-01-22
CZ20796A3 (en) 1996-10-16
US5872140A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
DE69414115T2 (de) Vitamin d analoge
BG103805A (en) Trifluoromethylalkylaminotriazolopyrimidines with fungicidal effect
DE3574014D1 (en) Novel biologically active compound having anti-prolyl endopeptidase activity
IL74497A0 (en) Pharmaceutical compositions and phenyl carbamate derivatives
AU1026599A (en) Acylsulfamoyl benzoic acid amides, plant protection agents containing said acylsulfamoyl benzoic acid amides, and method for producing the same
MY132115A (en) Novel thrombin inhibitors
ATE133181T1 (de) Dehydrodidemnin b
DE69412476T2 (de) Vitamin-d-amid-derivate
ES2148593T3 (es) Compuestos retinoides trienoicos novedosos y metodos.
AU4387296A (en) Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives and the use thereof as antiandrogens
NO981393D0 (no) Guanidinoproteasehemmere
ES2132651T3 (es) Derivados amidicos de la vitamina d.
GB2324091A (en) Metalloproteinase inhibitors
DK0742214T3 (da) I hjerte-kar-systemet aktive, nye seco-D steroider samt farmaceutiske præparater indeholdende sådanne
MX9700854A (es) Derivados de azabicicloheptano n-substituidos utiles como neurolepticos.
AU6722498A (en) Disubstituted biphenyloxazolines
YU23498A (sh) Herbicidni 3,5-difluoropiridini
BR9407232A (pt) Compostos de tiocarbamoíla
ITMI931808A1 (it) Derivati ossimici dell'acido formilfenilacetamido-cefalosporanico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee